Minmin Shi

3.7k total citations
81 papers, 2.2k citations indexed

About

Minmin Shi is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Minmin Shi has authored 81 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Molecular Biology, 29 papers in Oncology and 27 papers in Cancer Research. Recurrent topics in Minmin Shi's work include Pancreatic and Hepatic Oncology Research (15 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (11 papers). Minmin Shi is often cited by papers focused on Pancreatic and Hepatic Oncology Research (15 papers), RNA modifications and cancer (14 papers) and Cancer-related molecular mechanisms research (11 papers). Minmin Shi collaborates with scholars based in China, United States and Macao. Minmin Shi's co-authors include Chenghong Peng, Baiyong Shen, Hao Chen, Xiao‐Jun Huang, Yuan Kong, Lan‐Ping Xu, Yu Wang, Xiaxing Deng, Baiyong Shen and Chenlei Wen and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Minmin Shi

74 papers receiving 2.1k citations

Peers

Countries citing papers authored by Minmin Shi

Since Specialization

Citations

This map shows the geographic impact of Minmin Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Minmin Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Minmin Shi more than expected).

Fields of papers citing papers by Minmin Shi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Minmin Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Minmin Shi. The network helps show where Minmin Shi may publish in the future.

Co-authorship network of co-authors of Minmin Shi

This figure shows the co-authorship network connecting the top 25 collaborators of Minmin Shi. A scholar is included among the top collaborators of Minmin Shi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Minmin Shi. Minmin Shi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CEMIP2 sensitizes PDAC to chemotherapy through extracellular matrix remodeling by hyaluronan degradation 2025 ·Cancer Letters ·(unknown), (unknown), Ting Wang, Jiejie Qin, Yizhi Cao, Minmin Shi, Fangfang Ma, Baiyong Shen, Lingxi Jiang	1
2	TFAP2A enhances tumor stemness and promotes metastasis in pancreatic ductal adenocarcinoma 2025 ·iScience ·Jiaxin Luo, Zhenyu Ding, Dongjie Chen, (unknown), Yizhi Cao, Minmin Shi, Xiaomei Tang, Jia Liu, Meilin Xue, Zehui Zhang, (unknown), (unknown), Fangfang Ma, Ting Wang, Lingxi Jiang	0
3	Enhancing prognostic accuracy in head and neck squamous cell carcinoma chemotherapy via a lipid metabolism-related clustered polygenic model 2023 ·Cancer Cell International ·(unknown), Hao Wang, Fan Cui, Qianqian Song, Rui Ding, (unknown), (unknown), Kaili Chen, (unknown), Qing Wen, Minmin Shi, Bin Ye, Da Fu, Mingliang Xiang	4
4	Exosomal hsa-let-7g-3p and hsa-miR-10395-3p derived from peritoneal lavage predict peritoneal metastasis and the efficacy of neoadjuvant intraperitoneal and systemic chemotherapy in patients with gastric cancer 2023 ·Gastric Cancer ·Jiaxin Luo, Lingxi Jiang, Changyu He, Minmin Shi, Zhongyin Yang, Min Shi, Sheng Lu, Chen Li, Jun Zhang, Min Yan, Zhenggang Zhu, Chao Yan	10
5	Exploring the adaptive leisure activities of classified nursing model in elderly colon cancer patients: a perspective on interactive care 2023 ·BMC Palliative Care ·(unknown), (unknown), (unknown), Jiali Chen, Minmin Shi, (unknown)	0
6	High CTCF expression mediated by FGD5-AS1/miR-19a-3p axis is associated with immunosuppression and pancreatic cancer progression 2023 ·Heliyon ·(unknown), (unknown), (unknown), Xirui He, Songqi Duan, (unknown), Chen Li, Minmin Shi, Jiao Wang, (unknown)	0
7	LIPH contributes to glycolytic phenotype in pancreatic ductal adenocarcinoma by activating LPA/LPAR axis and maintaining ALDOA stability 2023 ·Journal of Translational Medicine ·(unknown), (unknown), Minmin Shi, (unknown), Zhichong Wu, Meilin Xue, Youwei Zhu, (unknown), Ting Wang, Xiaozhu Lin, Baiyong Shen, Lingxi Jiang, Hao Chen	10
8	Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma 2023 ·Cancer Immunology Immunotherapy ·Yongsheng Jiang, Lijie Han, Jian Yang, Minwei Yang, Jiän Zhang, Meilin Xue, Youwei Zhu, (unknown), Minmin Shi, Shiwei Zhao, Baiyong Shen, Zhiwei Xu, Lingxi Jiang, Hao Chen	5
9	PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor 2022 ·Journal of Experimental & Clinical Cancer Research ·Lingxi Jiang, Xia Wang, Fangfang Ma, Xuelong Wang, Minmin Shi, Qian Yan, Ming Liu, Juan Chen, Chaoran Shi, Xin‐Yuan Guan	10
10	EFEMP2 Suppresses the Invasion of Lung Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition (EMT) and Down-Regulating MMPs 2020 ·SHILAP Revista de lepidopterología ·Li Song, Xiaoxing Li, Yang Liu, Zhicheng Wang, Yang Yu, Minmin Shi, Bao‐Chun Jiang, (unknown)	2
11	Mycophenolate mofetil preconditioning protects mouse liver against ischemia/reperfusion injury in wild type and toll-like receptor 4 knockout mice 2020 ·Transplant Immunology ·(unknown), (unknown), Youwei Zhu, Meilin Xue, Yongsheng Jiang, Yiming Zhong, Lingxi Jiang, Hao Chen, Minmin Shi	2
12	Development and validation of a cancer stem cell-related signature for prognostic prediction in pancreatic ductal adenocarcinoma 2020 ·Journal of Translational Medicine ·(unknown), Minmin Shi, Kexian Li, Yang Ma, Lingxi Jiang, Hao Chen, Chenghong Peng	25
13	Cell-Cycle–Dependent Phosphorylation of PRPS1 Fuels Nucleotide Synthesis and Promotes Tumorigenesis 2019 ·Cancer Research ·Xiaoqian Jing, (unknown), (unknown), Wencheng Zhu, Yi Fang, Haoxuan Wu, Xinyu Liu, Ding Ma, Xiaopin Ji, Yimei Jiang, Kun Liu, (unknown), Yi Shi, Yaqi Zhang, Minmin Shi, Weihua Qiu, Ren Zhao	31
14	Dexmedetomidine for the prevention of emergence delirium and postoperative behavioral changes in pediatric patients with sevoflurane anesthesia: a double-blind, randomized trial 2019 ·SHILAP Revista de lepidopterología ·Minmin Shi, Song Miao, Tao Gu, Deheng Wang, Hongye Zhang, Jia Liu	10
15	Survival outcomes and efficacy of autologous CD19 chimeric antigen receptor-T cell therapy in the patient with diagnosed hematological malignancies: a systematic review and meta-analysis 2019 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), Juanjuan Song, Minmin Shi, (unknown)	1
16	Up-regulation of chemokine receptor CCR4 is associated with Human Hepatocellular Carcinoma malignant behavior 2017 ·Scientific Reports ·Xi Cheng, Huo Wu, Zhijian Jin, Ding Ma, (unknown), Xiaoqian Jing, Minmin Shi, Baiyong Shen, Chenghong Peng, Ren Zhao, Weihua Qiu	48
17	Mesenchymal Stem Cells Promote Liver Regeneration and Prolong Survival in Small-For-Size Liver Grafts: Involvement of C-Jun N-Terminal Kinase, Cyclin D1, and NF-κB 2014 ·PLoS ONE ·Weijie Wang, Zhiyong Du, Jiqi Yan, Di Ma, Minmin Shi, Mingjun Zhang, Chenghong Peng, Hongwei Li	39
18	Rapamycin Ameliorates Inflammation and Fibrosis in the Early Phase of Cirrhotic Portal Hypertension in Rats through Inhibition of mTORC1 but Not mTORC2 2014 ·PLoS ONE ·Weijie Wang, Jiqi Yan, (unknown), Minmin Shi, Mingjun Zhang, Weiping Yang, Chenghong Peng, Hongwei Li	52
19	Andrographolide causes apoptosis via inactivation of STAT3 and Akt and potentiates antitumor activity of gemcitabine in pancreatic cancer 2013 ·Toxicology Letters ·(unknown), Baiyong Shen, (unknown), Yajing Zhang, Minmin Shi, Chenghong Peng	41
20	Single Nucleotide Polymorphisms of Toll-Like Receptor 4 Decrease the Risk of Development of Hepatocellular Carcinoma 2011 ·PLoS ONE ·Minmin Shi, (unknown), Hao Chen, (unknown), Xiaxing Deng, (unknown), (unknown), (unknown), Songyao Jiang	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact